15250-m-cuypers

167 Care providers evaluation of DA and usual information 8 15. Mols F, Korfage IJ, Vingerhoets AJJM, Kil PJM, Coebergh JWW, Essink-Bot M-L, et al. Bowel, Urinary, and Sexual Problems Among Long-Term Prostate Cancer Survivors: A Population- Based Study. International Journal of Radiation Oncology*Biology*Physics. 2009;73(1):30-8. 16. Bellardita L, Valdagni R, van den Bergh R, Randsdorp H, Repetto C, Venderbos LDF, et al. How Does Active Surveillance for Prostate Cancer Affect Quality of Life? A Systematic Review. European Urology. 2015;67(4):637-45. 17. Punnen S, Cowan JE, Chan JM, Carroll PR, Cooperberg MR. Long-term Health-related Quality of Life After Primary Treatment for Localized Prostate Cancer: Results from the CaPSURE Registry. European Urology. 2015;68(4):600-8. 18. Heidenreich A, Bastian PJ, Bellmunt J, Bolla M, Joniau S, van der Kwast T, et al. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent— update 2013. Eur Urol. 2014;65(1):124-37. 19. Cuypers M, Lamers RED, Kil PJM, The R, Karssen K, Van de Poll-Franse LV, et al. A global, incremental development method for a web-based prostate cancer treatment decision aid and usability testing in a Dutch clinical setting. Health Informatics Journal, in press. 20. Cuypers M, Lamers RED, Kil PJM, van de Poll-Franse LV, de Vries M. Impact of a web-based treatment decision aid for early-stage prostate cancer on shared decision-making and health outcomes: study protocol for a randomized controlled trial. Trials. 2015;16(1):1-10. 21. Fleuren MA, Paulussen TG, Van Dommelen P, Van Buuren S. Towards a measurement instrument for determinants of innovations. Int J Qual Health Care. 2014;26(5):501-10. 22. FleurenM, PaulussenT, Van Dommelen P, Van Buuren S. Meetinstrument voor determinanten van innovaties (MIDI). Leiden: TNO. 2012. 23. Rozema AD, Mathijssen JJP, JansenMWJ, vanOers JAM. Schools as smoke-free zones? Barriers and facilitators to the adoption of outdoor school ground smoking bans at secondary schools. Tobacco Induced Diseases. 2016;14(1):10. 24. SijpkensMK,SteegersEAP,RosmanAN.FacilitatorsandBarriersforSuccessfulImplementation of Interconception Care in Preventive Child Health Care Services in the Netherlands. Maternal and Child Health Journal. 2016;20(1):117-24. 25. Grol R, Wensing M. What drives change? Barriers to and incentives for achieving evidence- based practice. Med J Aust. 2004;180. 26. Lamers RED, Cuypers M, de Vries M, van de Poll-Franse LV, Ruud Bosch JLH, Kil PJM. How do patients choose between active surveillance, radical prostatectomy, and radiotherapy? The effect of a preference-sensitive decision aid on treatment decision making for localized prostate cancer. Urologic Oncology: Seminars and Original Investigations. 2016. 27. Feldman-Stewart D, Tong C, Siemens R, Alibhai S, Pickles T, Robinson J, et al. The Impact of Explicit Values Clarification Exercises in a Patient Decision Aid Emerges After the Decision Is Actually Made: Evidence From a Randomized Controlled Trial. Medical Decision Making. 2012;32(4):616-26. 28. Légaré F, Thompson-Leduc P. Twelvemyths about shared decisionmaking. Patient Education and Counseling. 2014;96(3):281-6.